<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H9EEC7D776A284D6C835DBF7E66C6FAA3" key="H" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>115 HR 3382 IH: Youth Opioid Use Treatment Help Act of 2017</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2017-07-25</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">115th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 3382</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20170725">July 25, 2017</action-date><action-desc><sponsor name-id="C001101">Ms. Clark of Massachusetts</sponsor> (for herself and <cosponsor name-id="B001275">Mr. Bucshon</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Public Health Service Act to better address substance use and substance use disorders
			 among young people.</official-title></form>
	<legis-body id="HD05ACF8C92424A74BB46119B03938B2F" style="OLC">
 <section id="H5B72F3903DA440A9826DD5E2FD7C6CB9" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Youth Opioid Use Treatment Help Act of 2017</short-title></quote> or the <quote><short-title>YOUTH Act</short-title></quote>.</text> </section><section commented="no" id="H1C97B8C8275F47CA9BCCE32DC1C00E32"><enum>2.</enum><header>Reauthorization of substance abuse treatment services for children, adolescents, and young adults</header> <text display-inline="no-display-inline">Section 514 of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/290bb-7">42 U.S.C. 290bb–7</external-xref>) is amended—</text>
 <paragraph id="H66E37256A00D41D88F59E182E3CA784A"><enum>(1)</enum><text>in the section heading, by striking <quote><header-in-text level="section" style="OLC">children and adolescents</header-in-text></quote> and inserting <quote><header-in-text level="section" style="OLC">children, adolescents, and young adults</header-in-text></quote>;</text> </paragraph><paragraph id="HAD41C9F5C6674DB7AF414012DF01903F"><enum>(2)</enum><text display-inline="yes-display-inline">in subsection (a)(2), by striking <quote>children, including</quote> and inserting <quote>children, adolescents, and young adults, including</quote>; and</text>
 </paragraph><paragraph id="HEAB046361D394FD5B1B4CCA192AC3694"><enum>(3)</enum><text>by striking <quote>children and adolescents</quote> each place it appears and inserting <quote>children, adolescents, and young adults</quote>.</text> </paragraph></section><section id="H50BA224861BF4E1A96B3A237B0CAC982"><enum>3.</enum><header>Access to medication-assisted treatment for adolescents and young adults demonstration program</header> <subsection id="HCE3E378471B44E659D00FBA378575558"><enum>(a)</enum><header>In general</header><text>The Secretary of Health and Human Services, acting through the Director of the Agency for Healthcare Research and Quality (in this section referred to as the <quote>Director</quote>), shall award grants to eligible entities to establish demonstration programs to—</text>
 <paragraph id="HA104C487FD024144BF80BA96D503A6F9"><enum>(1)</enum><text>expand access to medication-assisted treatment for opioid use disorders among adolescents and young adults;</text>
 </paragraph><paragraph id="H57C5C270F2794CFCBA7D290BD3848986"><enum>(2)</enum><text display-inline="yes-display-inline">identify and test solutions for overcoming barriers to implementation of medication-assisted treatment for adolescents and young adults; or</text>
 </paragraph><paragraph id="HBF477CFBCFFC4735B8F495F640A0603B"><enum>(3)</enum><text display-inline="yes-display-inline">create and distribute resources on medication-assisted treatment training and implementation for providers of health care to children, adolescents, and young adults.</text>
 </paragraph></subsection><subsection id="H2633FEC0AB584DD2A0E90326F9A06566"><enum>(b)</enum><header>Eligible entities</header><text>To be eligible to receive a grant under subsection (a), an entity shall—</text> <paragraph id="H81800FCEA7C74E7A981CA11B69D8B052"><enum>(1)</enum><text display-inline="yes-display-inline">be a State, political subdivision of a State, Indian tribe, or tribal organization, professional family medicine provider organization, professional pediatric provider organization or other organization representing providers of health care to children, adolescents, and young adults, professional addiction medicine provider organization, hospital, an institution of higher education, or other appropriate public or nonprofit institution; and</text>
 </paragraph><paragraph id="H1052897F9D4B489D8916D59544D5EF66"><enum>(2)</enum><text>certify that it is in compliance with all applicable registration and licensing requirements.</text> </paragraph></subsection><subsection id="H2621562F08864675A1826E80F5B08574"><enum>(c)</enum><header>Application</header><text>To seek a grant under this section, an entity shall submit to the Director an application at such time, in such manner, and containing such information as the Director may require.</text>
 </subsection><subsection id="HA8A9130A98D042B8A45A4FD0B5094A1C"><enum>(d)</enum><header>Duration</header><text display-inline="yes-display-inline">An eligible entity may receive funds under this section to carry out a demonstration program described in this section for a period of not greater than 3 years. After the first year for which funding is provided to an eligible entity for a demonstration program, funding may be provided under this section for a subsequent year for such program only upon review of such program by the Director and approval by the Director of such subsequent year of funding.</text>
			</subsection><subsection id="HE4C5F4C17CB14F6EBA9D53791800FEC5"><enum>(e)</enum><header>Reports</header>
 <paragraph id="HF23B23129C404BEABEA7B0B131EF8029"><enum>(1)</enum><header>By grant recipients</header><text display-inline="yes-display-inline">Each eligible entity awarded a grant under this section for a demonstration program shall submit to the Director progress reports on such demonstration program at such times, in such manner, and containing such information as the Director may require.</text>
 </paragraph><paragraph id="H24421AC671FB41CB86DED85954F8D5F8"><enum>(2)</enum><header>By Director</header><text display-inline="yes-display-inline">Not later than one year after the date on which all demonstration programs funded under this section have been completed, the Director shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate, and the Committee on Energy and Commerce of the House of Representatives a report that—</text>
 <subparagraph id="HFE025993A5F2451294ED9A5892082639"><enum>(A)</enum><text display-inline="yes-display-inline">describes the availability of medication-assisted treatment for adolescents and young adults with opioid use disorders in the United States, including barriers to such treatment;</text>
 </subparagraph><subparagraph id="HBB0235271686465E8EDA873A3559E2BA"><enum>(B)</enum><text display-inline="yes-display-inline">describes the specific demonstration programs carried out pursuant to this section;</text> </subparagraph><subparagraph id="H96DD34500F06440BB1564D3A2692F026"><enum>(C)</enum><text display-inline="yes-display-inline">evaluates the effectiveness of such programs;</text>
 </subparagraph><subparagraph id="H75A6017770E1486EB7BE642B2CEEBE57"><enum>(D)</enum><text display-inline="yes-display-inline">evaluates any unintended consequences of such programs; and</text> </subparagraph><subparagraph id="H15B95AB9AEE8490ABC11CF70FADF5C86"><enum>(E)</enum><text>provides recommendations for ensuring that medication-assisted treatment is accessible to adolescents and young adults with opioid use disorders.</text>
 </subparagraph></paragraph></subsection><subsection id="HA55FB3C481524BEB90B045A34FE76EA3"><enum>(f)</enum><header>Definitions</header><text>In this section:</text> <paragraph id="H6DE134EA5E944420978B90F530352D94"><enum>(1)</enum><text display-inline="yes-display-inline">The phrase <quote>adolescents and young adults</quote> means individuals who have attained 10 years of age and not yet attained 26 years of age.</text>
 </paragraph><paragraph id="H824AC0363E374447B37881EE487F09EF"><enum>(2)</enum><text display-inline="yes-display-inline">The term <quote>medication-assisted treatment</quote> means the combination of pharmacological treatments approved by the Food and Drug Administration, and counseling and behavioral therapies, for the treatment of substance use disorders.</text>
 </paragraph><paragraph id="H47D95A18F0E54932846C4D5FFEAA70A5"><enum>(3)</enum><text>The term <term>opioid use disorder</term> means a problematic pattern of opioid use leading to clinically significant impairment or distress occurring within a 12-month period.</text>
 </paragraph><paragraph id="H1EA39D40878B4705A2E5F7789C48B77B"><enum>(4)</enum><text display-inline="yes-display-inline">The term <term>pediatric health care provider</term> means a provider of health care to individuals who have attained 10 years of age and not yet attained 26 years of age.</text>
 </paragraph><paragraph id="H1098A92FBB5D40E493DBA9ADB86F9897"><enum>(5)</enum><text>The term <term>professional family medicine provider organization</term> means a national organization whose members consist primarily of family medicine providers.</text> </paragraph><paragraph id="H6AA32FA0105640C6941B0D41886838A0"><enum>(6)</enum><text>The term <term>professional pediatric provider organization</term> means a national organization whose members consist primarily of pediatric health care providers.</text>
 </paragraph></subsection><subsection id="H3BE6995422424D1186994826B11D1206"><enum>(g)</enum><header>Authorization of appropriations</header><text display-inline="yes-display-inline">There is authorized to be appropriated $5,000,000 to carry out this section.</text> </subsection></section></legis-body></bill> 

